Literature DB >> 33410748

Diverse viral proteases activate the NLRP1 inflammasome.

Brian V Tsu1, Christopher Beierschmitt1, Andrew P Ryan1, Rimjhim Agarwal2, Patrick S Mitchell2,3, Matthew D Daugherty1.   

Abstract

The NLRP1 inflammasome is a multiprotein complex that is a potent activator of inflammation. Mouse NLRP1B can be activated through proteolytic cleavage by the bacterial Lethal Toxin (LeTx) protease, resulting in degradation of the N-terminal domains of NLRP1B and liberation of the bioactive C-terminal domain, which includes the caspase activation and recruitment domain (CARD). However, natural pathogen-derived effectors that can activate human NLRP1 have remained unknown. Here, we use an evolutionary model to identify several proteases from diverse picornaviruses that cleave human NLRP1 within a rapidly evolving region of the protein, leading to host-specific and virus-specific activation of the NLRP1 inflammasome. Our work demonstrates that NLRP1 acts as a 'tripwire' to recognize the enzymatic function of a wide range of viral proteases and suggests that host mimicry of viral polyprotein cleavage sites can be an evolutionary strategy to activate a robust inflammatory immune response.
© 2021, Tsu et al.

Entities:  

Keywords:  NLRP1 inflammasome; effector-triggered immunity; host-virus evolution; human; immunology; infectious disease; inflammation; microbiology; mouse; pathogen-encoded proteases; picornaviruses; virus

Mesh:

Substances:

Year:  2021        PMID: 33410748      PMCID: PMC7857732          DOI: 10.7554/eLife.60609

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  91 in total

Review 1.  Effector-triggered immunity: from pathogen perception to robust defense.

Authors:  Haitao Cui; Kenichi Tsuda; Jane E Parker
Journal:  Annu Rev Plant Biol       Date:  2014-12-08       Impact factor: 26.379

2.  Homozygous NLRP1 gain-of-function mutation in siblings with a syndromic form of recurrent respiratory papillomatosis.

Authors:  Scott B Drutman; Filomeen Haerynck; Franklin L Zhong; David Hum; Nicholas J Hernandez; Serkan Belkaya; Franck Rapaport; Sarah Jill de Jong; David Creytens; Simon J Tavernier; Katrien Bonte; Sofie De Schepper; Jutte van der Werff Ten Bosch; Lazaro Lorenzo-Diaz; Andy Wullaert; Xavier Bossuyt; Gérard Orth; Vincent R Bonagura; Vivien Béziat; Laurent Abel; Emmanuelle Jouanguy; Bruno Reversade; Jean-Laurent Casanova
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-04       Impact factor: 11.205

3.  Frontline Science: Anthrax lethal toxin-induced, NLRP1-mediated IL-1β release is a neutrophil and PAD4-dependent event.

Authors:  Allison J Greaney; Makayla K Portley; Danielle O'Mard; Devorah Crown; Nolan K Maier; Megan A Mendenhall; Katrin D Mayer-Barber; Stephen H Leppla; Mahtab Moayeri
Journal:  J Leukoc Biol       Date:  2020-05-18       Impact factor: 4.962

4.  Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response.

Authors:  J Alain Kummer; Roel Broekhuizen; Helen Everett; Laetitia Agostini; Loes Kuijk; Fabio Martinon; Robin van Bruggen; Jürg Tschopp
Journal:  J Histochem Cytochem       Date:  2006-12-12       Impact factor: 2.479

5.  The N-end rule ubiquitin ligase UBR2 mediates NLRP1B inflammasome activation by anthrax lethal toxin.

Authors:  Hao Xu; Jianjin Shi; Hang Gao; Ying Liu; Zhenxiao Yang; Feng Shao; Na Dong
Journal:  EMBO J       Date:  2019-05-06       Impact factor: 11.598

6.  FIMO: scanning for occurrences of a given motif.

Authors:  Charles E Grant; Timothy L Bailey; William Stafford Noble
Journal:  Bioinformatics       Date:  2011-02-16       Impact factor: 6.937

7.  Inhibition of Dpp8/9 Activates the Nlrp1b Inflammasome.

Authors:  Marian C Okondo; Sahana D Rao; Cornelius Y Taabazuing; Ashley J Chui; Sarah E Poplawski; Darren C Johnson; Daniel A Bachovchin
Journal:  Cell Chem Biol       Date:  2018-01-27       Impact factor: 8.116

8.  RIG-I-like receptors evolved adaptively in mammals, with parallel evolution at LGP2 and RIG-I.

Authors:  Rachele Cagliani; Diego Forni; Claudia Tresoldi; Uberto Pozzoli; Giulia Filippi; Veronica Rainone; Luca De Gioia; Mario Clerici; Manuela Sironi
Journal:  J Mol Biol       Date:  2013-11-07       Impact factor: 5.469

9.  Use of host-like peptide motifs in viral proteins is a prevalent strategy in host-virus interactions.

Authors:  Tzachi Hagai; Ariel Azia; M Madan Babu; Raul Andino
Journal:  Cell Rep       Date:  2014-05-29       Impact factor: 9.423

10.  Human NLRP1 is a sensor for double-stranded RNA.

Authors:  Stefan Bauernfried; Matthias J Scherr; Andreas Pichlmair; Karl E Duderstadt; Veit Hornung
Journal:  Science       Date:  2020-11-26       Impact factor: 47.728

View more
  24 in total

Review 1.  Innate immune sensing by epithelial barriers.

Authors:  David A Constant; Timothy J Nice; Isabella Rauch
Journal:  Curr Opin Immunol       Date:  2021-08-13       Impact factor: 7.486

Review 2.  PHOrming the inflammasome: phosphorylation is a critical switch in inflammasome signalling.

Authors:  Chloe M McKee; Fabian A Fischer; Jelena S Bezbradica; Rebecca C Coll
Journal:  Biochem Soc Trans       Date:  2021-12-17       Impact factor: 5.407

3.  A C-terminal glutamine recognition mechanism revealed by E3 ligase TRIM7 structures.

Authors:  Xiao Liang; Jun Xiao; Xuzichao Li; Yujie Liu; Yao Lu; Yanan Wen; Zexing Li; Xing Che; Yongjian Ma; Xingyan Zhang; Yi Zhang; Deng Jian; Peihui Wang; Chenghao Xuan; Guimei Yu; Long Li; Heng Zhang
Journal:  Nat Chem Biol       Date:  2022-08-18       Impact factor: 16.174

4.  KSHV-encoded ORF45 activates human NLRP1 inflammasome.

Authors:  Xing Yang; Jingfan Zhou; Chengrong Liu; Yafei Qu; Weili Wang; Maggie Z X Xiao; Fanxiu Zhu; Zhenshan Liu; Qiming Liang
Journal:  Nat Immunol       Date:  2022-05-26       Impact factor: 31.250

5.  Viral protein activates the NLRP1 inflammasome.

Authors:  Ella Hartenian; Petr Broz
Journal:  Nat Immunol       Date:  2022-06       Impact factor: 31.250

Review 6.  Inflammasome activation: from molecular mechanisms to autoinflammation.

Authors:  Samuel Lara-Reyna; Emily A Caseley; Joanne Topping; François Rodrigues; Jorge Jimenez Macias; Sean E Lawler; Michael F McDermott
Journal:  Clin Transl Immunology       Date:  2022-07-07

7.  The Shigella Spp. Type III Effector Protein OspB Is a Cysteine Protease.

Authors:  Thomas E Wood; Kathleen A Westervelt; Jessica M Yoon; Heather D Eshleman; Roie Levy; Henry Burnes; Daniel J Slade; Cammie F Lesser; Marcia B Goldberg
Journal:  mBio       Date:  2022-05-31       Impact factor: 7.786

Review 8.  The inflammasomes: crosstalk between innate immunity and hematology.

Authors:  Valéria de Freitas Dutra; Vinicius Nunes Cordeiro Leal; Alessandra Pontillo
Journal:  Inflamm Res       Date:  2022-10-20       Impact factor: 6.986

9.  Dipeptidyl peptidase 9 sets a threshold for CARD8 inflammasome formation by sequestering its active C-terminal fragment.

Authors:  Humayun Sharif; L Robert Hollingsworth; Andrew R Griswold; Jeffrey C Hsiao; Qinghui Wang; Daniel A Bachovchin; Hao Wu
Journal:  Immunity       Date:  2021-05-20       Impact factor: 43.474

Review 10.  Chemical Modulation of Gasdermin-Mediated Pyroptosis and Therapeutic Potential.

Authors:  Christopher B Ryder; Hannah C Kondolf; Meghan E O'Keefe; Bowen Zhou; Derek W Abbott
Journal:  J Mol Biol       Date:  2021-08-03       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.